
Sign up to save your podcasts
Or


Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.

135 Listeners

318 Listeners

493 Listeners

66 Listeners

31 Listeners

76 Listeners

13 Listeners

17 Listeners

12 Listeners

0 Listeners

115 Listeners

57 Listeners

3,334 Listeners

197 Listeners

44 Listeners

22 Listeners

364 Listeners

189 Listeners

43 Listeners

0 Listeners